TotalMarketCap

Celularity

CELUNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$23.692 M

$0.73 -9.73%

Close of 6 Nov 2026

As of 6 Nov 2026, Celularity (CELU) has a market capitalization of $23.7M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$26.6M

#2893 by revenue

Earnings

-$91.7M

Loss-making

Shares outstanding

32,449,891

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #372Aardvark TherapeuticsAARD$24.5M
  2. #373Shuttle PharmaceuticalsSHPH$24.3M
  3. #374CelularityCELU$23.7M
  4. #375NextCureNXTC$23.6M
  5. #376China PharmaCPHI$23.5M

What if Celularity were worth as much as…

Open the what-if tool →

Gold $28.2T

$870,147.39

Per share 1,191,819× higher

Bitcoin $1.53T

$47,082.16

Per share 64,487× higher

Apple $5.02T

$154,566.34

Per share 211,706× higher

Or at a round number

$50.0M$100.0M$200.0M$500.0M

Where these numbers come from

Share counts and financials for Celularity are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.